| Company Name: | Akzo Nobel NV ADR | | Ticker Symbol: | AKZOY | | | WWW Address: | www.akzonobel.com |
| CEO: | G.J. Wijers | | No. of Employees: | 61,880 |
| Common Issue Type: | AD | | Business Description: | The Company is a diversified, multicultural company with activities in human and animal healthcare, coatings and chemicals.
|
| | | Industry Information: | INDUSTRIAL - Industrial Equipment & Components [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 20.36 |  -0.3 | 20.68 | 20.34 | 20.6 | 77.37 | 76.20 | 13744 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 5,680.4 | 279.0 | 1.20 | 5.28 | 0.00 | 15.4 | 0.0 | 88.88 - 53.63 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 76.33 | $ | | PE Ratio - LTM | 15.4 | |
| Market Capitalisation | 5,680.4 | mil |
| Latest Shares Outstanding | 279.0 | mil |
| Earnings pS (EPS) | 5.28 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 292,986 | $ |
| Effective Tax Rate | 18.0 | % |
| Float | 0.0 | mil |
| Float as % of Shares Outstanding | 0.0 | % |
| Foreign Sales | 16,922 | mil |
| Domestic Sales | 1,208 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 29.70 | % |
| Research & Devlopment (R&D) as % of Revenue | 4.80 | % |
| Gross Profit Margin | 46.7 | % |
| EBITDA Margin | 12.3 | % |
| Pre-Tax Profit Margin | 9.5 | % |
| Assets Turnover | 1.0 | % |
| Return on Assets (ROA) | 8.5 | % |
| Return on Equity (ROE) | 27.0 | % |
| Return on Capital Invested (ROCI) | 16.6 | % |
| Current Ratio | 2.1 | |
| Leverage Ratio (Assets/Equity) | 3.2 | |
| Interest Cover | 4.9 | |
| Total Debt/Equity (Gearing Ratio) | 0.69 | |
| LT Debt/Total Capital | 38.0 | % |
| Working Capital pS | 22.10 | $ |
| Cash pS | 7.04 | $ |
| Book-Value pS | 19.19 | $ |
| Tangible Book-Value pS | 16.54 | $ |
| Cash Flow pS | 7.37 | $ |
| Free Cash Flow pS | 1.27 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 3.98 | |
| Price/Tangible Book Ratio | 4.61 | |
| Price/Cash Flow | 10.4 | |
| Price/Free Cash Flow | 60.1 | |
| P/E as % of Industry Group | 80.0 | % |
| P/E as % of Sector Segment | 79.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | Cash & Stock Payment |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 2.5 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 30.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 7.0 | 105 | 1,349 | 6,513 |
| 4 Weeks | 83.32 | 69.20 | 82.10 | -7.0 | 92 | 1,325 | 26,498 |
| 13 Weeks | 88.88 | 69.20 | 79.93 | -4.5 | 98 | 878 | 55,286 |
| 26 Weeks | 88.88 | 58.24 | 61.45 | 24.2 | 122 | 809 | 102,792 |
| 52 Weeks | 88.88 | 53.63 | 56.65 | 34.7 | 118 | 690 | 172,389 |
| YTD | 88.88 | 58.24 | - | 25.4 | 120 | 775 | 126,396 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 75.01 | 74.89 | 82.77 | 76.43 | 71.94 | 1.20 | 1.05 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 3.60 | 48.8 | 0.62 |
| Income | 12.48 | 74.3 | 16.14 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | -0.65 | NA | 7.69 |
| R&D | 1.76 | NA | -4.97 |
| Normalized Inc. | 7.07 | NA | 2.94 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -21.2 | -20.5 | 17.8 |
| Earnings % | -10.5 | -21.0 | 33.9 |
| EPS % | -10.7 | -20.6 | 33.3 |
| EPS $ | -0.29 | -0.33 | 1.32 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 26.54 |
| Current Ratio | 1.9 |
| Quick Ratio (Acid Test) | 1.2 |
| Liquidity Ratio (Cash) | 0.51 |
| Receivables Turnover | 5.3 |
| Average Collection Period | 68 |
| Working Capital/Equity | 81.9 |
| Working Capital pS | 15.59 |
| Cash-Flow pS | 7.84 |
| Free Cash-Flow pS | -0.59 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 3.14 |
| Financial Leverage Ratio (Assets/Equity) | 3.1 |
| Debt Ratio | 67.6 |
| Total Debt/Equity (Gearing Ratio) | 0.71 |
| LT Debt/Equity | 0.62 |
| LT Debt/Capital Invested | 74.4 |
| LT Debt/Total Liabilities | 29.5 |
| Interest Cover | 7.0 |
| Interest/Capital Invested | 2.60 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 7.83 |
| Tobin's Q Ratio | 1.26 |
| Current P/E Ratio - LTM | 15.40 |
| Enterprise Value (EV)/EBITDA | 12.55 |
| Enterprise Value (EV)/Free Cash Flow | -217.39 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 4.61 |
| Price/Book Ratio - LTM | 3.98 |
| Price/Cash Flow Ratio | 10.4 |
| Price/Free Cash Flow Ratio - LTM | 60.1 |
| Price/Sales Ratio | 1.31 |
| P/E Ratio (1 month ago) - LTM | 17.4 |
| P/E Ratio (26 weeks ago) - LTM | 11.6 |
| P/E Ratio (52 weeks ago) - LTM | 12.2 |
| 5-Y High P/E Ratio | 15.7 |
| 5-Y Low P/E Ratio | 6.9 |
| 5-Y Average P/E Ratio | 11.7 |
| Current P/E Ratio as % of 5-Y Average P/E | 132 |
| P/E as % of Industry Group | 80.0 |
| P/E as % of Sector Segment | 79.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 14.8 |
| PER SHARE FIGURES |
| LT Debt pS | 11.72 |
| Current Liabilities pS | 16.81 |
| Tangible Book Value pS - LTM | 16.54 |
| Book Value pS - LTM | 19.19 |
| Capital Invested pS | 31.67 |
| Cash pS - LTM | 7.04 |
| Cash Flow pS - LTM | 7.37 |
| Free Cash Flow pS - LTM | 1.27 |
| Earnings pS (EPS) | 5.28 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -0.94 |
| Free Cash Flow Margin 5YEAR AVG | 0.77 |
| Net Profit Margin | 8.4 |
| Net Profit Margin - 5YEAR AVRG. | 6.6 |
| Equity Productivity | 3.32 |
| Return on Equity (ROE) | 27.8 |
| Return on Equity (ROE) - 5YEAR AVRG. | 28.6 |
| Capital Invested Productivity | 2.05 |
| Return on Capital Invested (ROCI) | 17.2 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 15.8 |
| Assets Productivity | 1.10 |
| Return on Assets (ROA) | 9.0 |
| Return on Assets (ROA) - 5YEAR AVRG. | 7.1 |
| Gross Profit Margin | 46.7 |
| Gross Profit Margin - 5YEAR AVRG. | 51.3 |
| EBITDA Margin - LTM | 12.3 |
| EBIT Margin - LTM | 11.9 |
| Pre-Tax Profit Margin | 10.5 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 9.1 |
| Effective Tax Rate | 18.0 |
| Effective Tax Rate - 5YEAR AVRG. | 24.9 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 171 |
| Revenue per Employee | 292,986 |
| Net Income per Employee | 24,596 |
| Average Collection Period | 70 |
| Receivables Turnover | 5.3 |
| Day's Inventory Turnover Ratio | 101 |
| Inventory Turnover | 3.6 |
| Inventory/Sales | 14.9 |
| Accounts Payble/Sales | 8.89 |
| Assets/Revenue | 0.91 |
| Net Working Capital Turnover | 4.05 |
| Fixed Assets Turnover | 2.40 |
| Total Assets Turnover | 1.1 |
| Revenue per $ Cash | 7.34 |
| Revenue per $ Plant | 4.11 |
| Revenue per $ Common Equity | 3.32 |
| Revenue per $ Capital Invested | 2.05 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 30.5 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 30.9 |
| Research & Devlopment (R&D) as % of Revenue | 6.4 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 6.4 |
|
|  
|
| |
 |  |
